-
-
-
-
-
-
-
Alector Announces FDA Fast Track Designation Granted to AL101 for the Treatment of Patients with Frontotemporal Dementia
-
-
-
-
-
-
-
Alector Announces Full Exercise of Underwriters' Option to Purchase Additional Shares in Public Offering
-
-
-
-
-
-
-
Alector Announces Proposed Public Offering of Common Stock
-
-
64,524 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

